This year promises to be an instrumental one in the realm of clinical research, from the developments of the Covid-19 vaccine and beyond. Today, we’ll be picking out a few significant clinical studies to keep an eye on in the months to come.
1. Clinical trial for rare illnesses
Disease Treatment: Rare illnesses
Company: Argenx
This Netherlands-based pharmaceutical company turned heads in 2020 with a clinical trial for efgartigimod, a drug that was shown to improve motor functions in those afflicted by the rare, chronic, autoimmune disease myasthenia gravis.
The kicker? The company finds its inspiration for drugs in llama antibodies. Now, Argenx awaits FDA approval for efgartigimod, with hopes to expand into Japan and Europe later this year.
2. New clinical trial for Alzheimer's disease
Disease Treatment: Alzheimer’s Disease
Company: Biogen
This clinical trial, testing a medication known as Aducanumab, is promising because of its method of turning antibodies into therapeutics by a process called "reverse translational medicine." The drug will be evaluated under priority review for FDA approval, with a target action date of March 7.
3. Clinical trial for multiple Myeloma
Disease Treatment: Late-stage multiple Myeloma
Company: Johnson and Johnson
This therapy, known as Cilta-ce,l is a CAR-T targeting BCMA (B-cell maturation antigen.) This year, a study researching its effects on refractory multiple myeloma is expected to yield FDA approval.
4. Clinical trial for Migraine prevention
Disease treatment: Migraine Prevention
Company: AbbVie, pre-registration.
The proposed drug, Atogepant is an oral calcitonin gene-related peptide receptor antagonist being tested as migraine prevention and treatment medication. After a phase III trial showing a reduction in average migraines over the course of three months, AbbVie’s drug is promising, given that oral methods of delivering the CGRP receptor agonist are more accessible to patients, and are becoming increasingly popular.
Stay Up to Date on Clinical Studies
Citrus is a fully integrated recruitment and retention software that fits any clinical trial and simplifies the implementation of patient engagement in your clinical trial. Whether you are already working with CTMS systems or not, Citrus is the perfect add-on to make patient interaction effective.
Since 2015, our team has been hard at work raising awareness of clinical trials across the globe. A Forbes ‘30 Under 30’ company and a graduate of the renowned Techstar program in New York, Citruslabs is at the forefront of patient recruitment and retention technologies. With over 3 million patients now recorded on our databases, our patient recruitment dashboard is fast becoming the most efficient method of trial recruitment.
Now a #1 health app in 17 countries, our Mindmate app is helping to revolutionize the way we think about healthcare. Mindmate “[takes] senior care into the digital age” (Forbes, 2018) by providing people with cognitive decline the essential tools to help them rebuild and maintain strong mental health. Trusted by millions of users, our health community continues to grow as the content available expands to the needs of individuals today.
With more than 200 research sites now using the Citrus platform to screen thousands of patients every month, researchers are now well on their way to finding new treatments for hundreds of different health conditions - something that just would not be possible without a technological solution. Make sure that your clinical trial is in the lucky 12% and turn that luck into guaranteed results with Citrus.
Check out what our customers have to say about us here.
And If you’d like to know more about how Citruslabs can help you recruit more effectively, get in touch with our team here.